Albemarle CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Capital World Investors has reported a 9.5% stake in Albemarle Corp. as of March 31, 2026, holding over 11.2 million shares.
NYSE
Vanguard Capital Management has reported a beneficial ownership of 7.37% in Albemarle Corp's common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.38% of Albemarle Corporation's common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Albemarle Corp following an internal realignment.
NYSE
Franklin Resources, Inc. has filed an amendment to its Schedule 13G, disclosing a 3.1% beneficial ownership stake in Albemarle Corporation as of December 31, 2025.
NYSE
Capital Research Global Investors has filed an amended Schedule 13G, reporting a 1.8% beneficial ownership stake in Albemarle Corp. common stock.
NYSE
State Street Corporation has reported a 4.8% beneficial ownership stake in Albemarle Corp common stock as of September 30, 2025.
NYSE
Franklin Resources, Inc. and its affiliates disclosed a 5.7% beneficial ownership in Albemarle Corporation's common stock, including convertible debt securities.
NYSE
SCHEDULE 13G/A: Capital World Investors Boosts Albemarle Stake to 8.4%
Capital World Investors has disclosed an 8.4% beneficial ownership stake in Albemarle Corp., holding over 10 million shares.
NYSE
Capital Research Global Investors has disclosed a 5.3% beneficial ownership stake in Albemarle Corp. common stock.
NYSE
Franklin Resources, Inc. and its affiliates have reported an 8.0% beneficial ownership stake in Albemarle Corporation, primarily for passive investment purposes.
NYSE
Capital Research Global Investors has filed an amended Schedule 13G, reporting a 5.0% beneficial ownership stake in Albemarle Corp. as of March 31, 2025.
NYSE
Franklin Resources, Inc. and its affiliates have filed a Schedule 13G, reporting a combined beneficial ownership of 7.0% in Albemarle Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, confirming its beneficial ownership of 8.1% of Albemarle Corporation's common stock as of March 31, 2025.
NYSE
Capital Research Global Investors has filed a Schedule 13G, reporting a 7.3% passive beneficial ownership stake in Albemarle Corp. as of December 31, 2024.